Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin PK in critically ill patients on ECMO
NCT05542446Phase 4Terminated
- Sponsor
- St. Anne's University Hospital Brno
- Start
- Sep 2022
- Primary completion
- Jan 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of colistin in bacterial infection (2 arms), sponsored by St. Anne's University Hospital Brno. Primary endpoint: Area under the plasma concentration versus time curve at 24 hours. Started Sep 2022; status: terminated.
02
Drugs
colistin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05542446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05542446.